Kelly A. Kramer - May 8, 2024 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Director
Signature
/s/ Edward S. Son by by Power of Attorney for Kelly A. Kramer
Stock symbol
GILD
Transactions as of
May 8, 2024
Transactions value $
$0
Form type
4
Date filed
5/9/2024, 03:38 PM
Previous filing
Jul 6, 2023
Next filing
Jun 18, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Award +2.31K +15.11% 17.6K May 8, 2024 Common Stock 2.31K Direct F1, F2
transaction GILD Non-qualified Stock Option (Right to Buy) Award $0 +12.6K $0.00 12.6K May 8, 2024 Common Stock 12.6K $64.92 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 100% of the restricted stock units vested immediately upon the grant date of May 8, 2024.
F3 100% of the shares subject to the stock option vested immediately upon the grant date of May 8, 2024.